| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006117392 |
| P356 | DOI | 10.1186/S12872-016-0324-1 |
| P932 | PMC publication ID | 4947282 |
| P698 | PubMed publication ID | 27422557 |
| P2093 | author name string | Xue Shen | |
| Jianjun Dong | |||
| Xiaojun Zhou | |||
| Lin Liao | |||
| Tianshu Yang | |||
| Ju Liu | |||
| Fupeng Liu | |||
| Yaru Mou | |||
| P2860 | cites work | A novel mouse model of in-stent restenosis | Q33755946 |
| A selective microRNA-based strategy inhibits restenosis while preserving endothelial function | Q34129012 | ||
| Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis | Q34203043 | ||
| Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling | Q35027354 | ||
| A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention | Q35532916 | ||
| Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation | Q35827332 | ||
| Statins--a cure-all for the brain? | Q36085649 | ||
| Preventing restenosis after angioplasty: a multistage approach | Q37056663 | ||
| Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics | Q37285418 | ||
| Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis | Q37511128 | ||
| Novel potential targets for prevention of arterial restenosis: insights from the pre-clinical research. | Q38235041 | ||
| Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial. | Q38451775 | ||
| Effects of design geometry of intravascular endoprostheses on stenosis rate in normal rabbits | Q39236547 | ||
| Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit | Q43470332 | ||
| Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). | Q43554122 | ||
| Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepat | Q43931722 | ||
| Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia | Q44363949 | ||
| Atorvastatin induces insulin sensitization in Zucker lean and fatty rats | Q46584762 | ||
| Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. | Q54728410 | ||
| Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group | Q72741422 | ||
| Effect of statin therapy on restenosis after coronary stent implantation | Q73665593 | ||
| Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty | Q73746075 | ||
| A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial | Q74601678 | ||
| Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin | Q80421878 | ||
| alpha8beta1 Integrin is up-regulated in the neointima concomitant with late luminal loss after balloon injury | Q80631726 | ||
| Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin | Q82915890 | ||
| Hyperglycemia has no effect on development of restenosis after percutaneous transluminal angioplasty (PTA) in a diabetic rabbit model | Q85939817 | ||
| P304 | page(s) | 153 | |
| P577 | publication date | 2016-07-16 | |
| P1433 | published in | BMC Cardiovascular Disorders | Q15753126 |
| P1476 | title | The role of atorvastatin on the restenosis process post-PTA in a diabetic rabbit model | |
| P478 | volume | 16 |
| Q51046456 | Atorvastatin treatment modulates p16 promoter methylation to regulate p16 expression. | cites work | P2860 |
Search more.